C. Daniel Myers

Chief Executive Officer, Alimera Sciences.

Companies

Kala Pharmaceuticals (United States)Board member Oct 19, 2021 to now¹
Alimera SciencesBoard member Apr 21, 2010 to Jan 6, 2023²
Alimera SciencesChief executive officer Apr 21, 2010 to Feb 8, 2018²
Alimera SciencesPresident Apr 21, 2010 to Nov 16, 2015²
Alimera SciencesOfficer Feb 14, 2012 to Feb 14, 2012³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kala Pharmaceuticals (United States) KALA10,374 shares⁴$2.0K at $0.19Jun 15, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 15, 2025Granted 2,450 shares of Kala Pharmaceuticals (United States)⁴
Jun 11, 2024Granted 1,400 shares of Kala Pharmaceuticals (United States)⁵
Jun 22, 2023Granted 1,100 shares of Kala Pharmaceuticals (United States)⁶
Jun 22, 2023Granted 3,784 shares of Kala Pharmaceuticals (United States)⁶
May 31, 2023Granted 1,640 shares of Kala Pharmaceuticals (United States)⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKala Pharmaceuticals (United States), Board member
2
SEC EDGARAlimera Sciences, Board member
3
SEC EDGARAlimera Sciences, Officer
4
SEC EDGARKala Pharmaceuticals (United States) shares after the filing of Jun 15, 2025
5
SEC EDGARForm 4 filed Jun 12, 2024
6
SEC EDGARForm 4 filed Jun 23, 2023
7
SEC EDGARForm 4 filed Jun 2, 2023